Y, E., T, N., T, Y., T, K., M, K., G, O., . . . K, E. (2025). Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study. Bone, 201, 117627. https://doi.org/10.1016/j.bone.2025.117627
Chicago Style (17th ed.) CitationY, Etani, et al. "Impact of Baseline PINP on the BMD Increase with Romosozumab, Teriparatide, and Denosumab in Treatment-naïve Primary Osteoporosis: A Retrospective Cohort Study." Bone 201 (2025): 117627. https://doi.org/10.1016/j.bone.2025.117627.
MLA (9th ed.) CitationY, Etani, et al. "Impact of Baseline PINP on the BMD Increase with Romosozumab, Teriparatide, and Denosumab in Treatment-naïve Primary Osteoporosis: A Retrospective Cohort Study." Bone, vol. 201, 2025, p. 117627, https://doi.org/10.1016/j.bone.2025.117627.